People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Amprion, Inc. | — | Biotechnology | Series A | $16.7M | $27.6M | 2022 |
| Marval Biosciences Inc | — | Biotechnology | Seed | $6.5M | $111.0M | 2011 |
| DX Biosciences, Inc. | — | Other | Pre-Seed | $829K | $12.2M | 2010 |
Russell Lebovitz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Russell Lebovitz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Frank Foster | 2 | 12 |
| Dan Watkins | 2 | 8 |
| Robert Langer | 1 | 36 |
| Samir Mitragotri | 1 | 4 |
| Rahul Bhansali | 1 | 2 |
| Daniel Haimovic | 1 | 2 |
| Sallie Cassel | 1 | 1 |
| MyPhuong Lam | 1 | 1 |
| Ananth Annapragada | 1 | 1 |
| Marc Chan | 1 | 1 |
| Claudio Soto | 1 | 1 |
| Peter Clinton | 1 | 1 |
| Kenneth Lehman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.